Editorial Board ::: Current Alzheimer Research

ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)


Volume 13, 12 Issues, 2016


Download PDF Flyer




Current Alzheimer Research

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 59th of 192 in Clinical Neurology
  • 101st of 256 in Neurosciences

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Debomoy K. Lahiri
Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.145
5 - Year: 3.58

Editorial Board

Editor-in-Chief:

Debomoy K. Lahiri (Biography
Debomoy K. Lahiri

Dr. Debomoy Lahiri is Professor at Indiana University School of Medicine, USA. His major research focus is to understand the mechanism of aging, origin and biogenesis of the amyloid plaque, and to discover drug targets for Alzheimer's disease (AD) and other brain disorders. Dr. Lahiri’s group has shown the novel role of specific microRNA species in regulation of genes implicated in AD as well as the role of gene and environment interaction in late-life disorders. Also, his team has made significant contributions to understanding the biochemical pathway for neurodevelopment disorders, such as autism and fragile X syndrome. Dr. Lahiri is the Editor-In-Chief of the international journal, ‘Current Alzheimer Research' (Bentham). He authored books, such as ‘Protective Strategies for Neurodegenerative Diseases' published by the New York Academy of Sciences. Dr. Lahiri was awarded grants as a Principal Investigator from the National Institute on Aging, NIH, and Alzheimer’s Association, USA. His other honors include the ‘Zenith Award’ and listing in Marquis' ‘Who's Who in the World'.

)

Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202
USA



Honorary Senior Advisor(s):

Jean-Marie Lehn
(Nobel Laureate)
Laboratoire de Chimie
Supramoléculaire ISIS
Université de Strasbourg
Strasbourg
France

Ferid Murad
(Nobel Laureate)
University Professor Director
Institute of Molecular and Cellular Signaling
Department of Biochemistry and Molecular Biology
Washington, DC
USA


Associate Editor(s):

Sultan Darvesh (Biography
Sultan Darvesh

Dr. Darvesh completed his PhD (organic chemistry) and postdoctoral fellowship (molecular biology) at the University of New Brunswick, Fredericton, Canada. He completed medical training (MD) and residency (Neurology) at Dalhousie University, Halifax, Canada, and a fellowship in Behavioural Neurology, The Baycrest Center for Geriatric Care and the University of Toronto, Canada. He is a Professor and Staff Neurologist, Department of Medicine (Neurology and Geriatric Medicine), Queen Elizabeth II Health Sciences Centre, Halifax, Canada, and cross-appointed in the Department of Medical Neuroscience, Dalhousie University. He has published more than 80 publications and is an inventor of 12 patents and 1 copyright.

)

Dalhousie University
Halifax, NS
Canada

Gad A. Marshall (Biography
Gad A. Marshall

Dr. Marshall is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. He has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and am currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 2, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living and neuropsychiatric symptoms with PiB and FDG PET, structural and resting-state functional MRI, and CSF biomarkers across the early Alzheimer’s disease spectrum. He is an Associate Editor for Current Alzheimer Research and the Journal of Alzheimer’s Disease and an ad-hoc reviewer for 26 other journals.

)

Brigham and Women's Hospital
Massachusetts General Hospital
Harvard Medical School
Boston, MA
USA

Weihong Song (Biography
Weihong Song

Dr. Song is the Canada Research Chair in Alzheimer's disease and a Professor in the Department of Psychiatry at UBC. He was trained as a clinical psychiatrist and molecular neuroscientist (http://neuroscience.ubc.ca/people/Song). His lab has made major contribution to the understanding on how BACE1 and γ-secretase regulate APP processing and their role in Alzheimer pathogenesis and drug development. He also investigates the molecular pathways contributing to AD pathogenesis in Down Syndrome. He serves on numerous international grant review panels and journals’ editorial boards. Dr. Song was elected to Fellowship in the Canadian Academy of Health Sciences (CAHS) in 2012.

)

The University of British Columbia
Vancouver
Canada

Martin R. Farlow (Biography
Martin R. Farlow

Dr. Farlow is Professor of Neurology and Vice-Chairman of Research in the Department of Neurology at the Indiana University School of Medicine in Indianapolis. He is also Associate Co-Director of the Indiana Alzheimer’s Disease Center in Indianapolis. Dr. Farlow is a member of many professional associations including the American Academy of Neurology, the American Neurological Association, and the American Geriatrics Society. He is also a founding member in both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology. Dr. Farlow has lectured on the topics of aging, dementia, and Alzheimer’s disease at more than 300 meetings, conferences, and hospitals/medical schools throughout the world. He is a reviewer for numerous scientific journals and on the editorial boards of MedLink and Current Alzheimer Research. Dr. Farlow’s research focuses on clinical trials of investigational drugs for the treatment of Alzheimer’s disease and related dementias being the lead investigator for several major studies including; tacrine, donepezil, rivastigmine and interests in trial design and safety.

)

Indiana University School of Medicine
Indianapolis, IN
USA

George Perry (Biography
George Perry

George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the Scrippss Institution of Oceanography at San Diego. He is distinguished as one of the top Alzheimer’s disease researchers by Expertscape with over 1000 publications, more than 66,000 citations (H=129), one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished University Chair in Neurobiology and is an active participant in many other scientific associations. He is an elected member of the Academies of Sciences of Mexico, Portugal, and Spain. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Disease which he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.

)

University of Texas at San Antonio
Texas, TX
USA

Nigel H. Greig
National Institute on Aging/NIH
Baltimore, MD
USA

Lon S. Schneider
University of Southern California, Keck School of Medicine
Los Angeles, CA
USA


Regional Editor(s):

Konrad Beyreuther
University Heidelberg
Heidelberg
Germany

Frederic Checler (Biography
Frederic Checler

Dr. Checler received his PhD in Cellular and Molecular Pharmacology from University of Nice-Sophia-Antipolis (1983). Frédéric Checler was ranked Top 1% researcher in the world “Biology and Biochemistry” (ISI WOK field of ranking at the end of 2011) and published over 250 articles. Dr. Checler was the first President of the scientific committee of the European League against Alzheimer’s disease (LECMA, 2005-2010) and has been member of the editorial board (1993-2001) and deputy Chief Editor (20001-2010) of J. Neurochem and currently European Editor of Current Alzheimer Research and senior editor of Scientific Reports.

)

Institut de Pharmacologie Moleculaire et Cellulaire
Valbonne
France


Editorial Board Members:

Craig Atwood (Biography
Craig Atwood

Dr. Atwood obtained his Ph.D. in Biochemistry from the University of Western Australia, Perth, Australia. He has held faculty positions at Harvard Medical School and Case Western Reserve University prior to his current appointments as an Associate Professor in the University of Wisconsin-Madison Department of Medicine, and as a Health Science Specialist within the Geriatric Research, Education and Clinical Center at the William S. Middleton Memorial Veterans Administration Hospital, Madison. He has published more than 150 scientific publications, is an inventor on 8 issued U.S. patents and is a top cited author. He has received a number of awards for his teaching and research, including the Zenith Fellows Award from the Alzheimer’s Association.

)

University of Wisconsin-Madison, School of Medicine
Madison, WI
USA

Nady Braidy (Biography
Nady Braidy

Dr Nady Braidy is a neuroscientist with a Ph.D. degree that was awarded to him in 2011 from the University of New South Wales, Sydney, NSW, Australia. Dr. Braidy has international recognition in the field of Alzheimer research and specializes in neural cell therapeutics. Dr. Braidy also holds a graduate certificate in research management (with distinction), Diploma in innovation management (with distinction), M.S. degree in pharmacy, University of Sydney, and B.S. degree in medical science (class I honors in pharmacology and physiology with distinction) University of New South Wales. Dr. Braidy has published over 80 peer-reviewed research papers, 5 book chapters, and 2 books and is an inventor in 1 accepted international patent.

)

University of New South Wales
Sydney
Australia

Rudy J. Castellani
University of Maryland
Baltimore, MD
USA

Colin K. Combs (Biography
Colin K. Combs

Dr. Combs obtained a doctorate (PhD) in Neurobiology and Anatomy from the University of Rochester, Rochester, NY. He performed his post-doctoral studies at Case Western Reserve University in the Department of Neurosciences in the Alzheimer’s Research Laboratory in Cleveland, OH. Dr. Combs is a Professor in the Department of Biomedical Sciences at the University of North Dakota School of Medicine and Health Sciences in Grand Forks, ND. His work has focused on neuroinflammatory aspects of Alzheimer’s disease and microglial activation along with the biology of amyloid precursor protein.

)

University of North Dakota
School of Medicine and Health Sciences
Grand Forks, ND
USA

Isidro Ferrer (Biography
Isidro Ferrer

Isidro Ferrer, born in Barcelona, Spain in 1951, Graduate in Medicine in 1976, Doctor in Medicine in 1980 at the University of Barcelona. Professor of Pathology, Department of Pathology and Experimental Therapeutics, University of Barcelona; Director of the Institute of Neuropathology and Brain Bank, Bellvitge Universiy Hospitaltge, Hospitalet de Llobregat, Barcelona; PI of the group Neuropathology at the Biomedical Network Center for Research on Neurodegenerative Diseases (CIBERNED), Institute of Health Carlos III, Spain. Main topics of interest: Morphological and molecular neuropathology of aging and human neurodegenerative diseases in old age including Alzheimer’s disease, tauopathies, alpha-synucleinopathies, prion diseases, amyotrophic lateral sclerosis and frontoemporal lobar degenerations, among others. Publications: 690 publications in scientific journals; 32 book chapters.

)

Institute de Neuropatologia
Carrer Feixa Llarga sn 08907 Hospitalet de Llobregat
Spain

Othman Ghribi (Biography
Othman Ghribi

Othman Ghribi has completed his Ph.D in Neuropharmacology in 1994 at the University René Descartes, Paris France, and postdoctoral studies from The University of Quebec (1996-1999). Dr Ghribi then joined the Department of Pathology at the University of Virginia (1999-2004) and the Department of Biomedical Sciences at the University of North Dakota School of Medicine in 2004. He has published more than 80 papers and is serving on the Editorial Board of The Journal of Alzheimer’s Disease, Current Alzheimer’s disease, and the Journal of Neurodegenerative Diseases. Dr. Ghribi’s current research is funded by the national Institute of Health and focuses on the role of environmental factors (chemical and dietary) and genetic susceptibility in the pathophysiology of Alzheimer’s disease.

)

University of North Dakota, School of Medicine
Grand Forks, ND
USA

Yue Huang (Biography
Yue Huang

Dr. Huang, Yue obtained MBBS degree from Harbin Medical University, China in 1991, trained as a neurologist, and practiced in clinics for nine years. She started her postdoctoral research in neuropathology at Neuroscience Research Australia in Sydney, Australia in 2003, following her PhD completion on neurogenetics (Capital Medical University, Beijing, China) and proteomics (Flinders University, SA, Australia). Her research interest is neurodegenerative disorders. Currently, Dr. Huang, Yue is a conjoint associate professor in UNSW Australia, and an honorary neuropathology consultant in Human Brain Tissue Bank of Peking Union Medical College.

)

The University of New South Wales
Sydney
Australia

Jianping Jia (Biography
Jianping Jia

Prof. Jia is Senior Physician and Professor in Neurology, Dean of Neurology College,Beijing Capital Medical University, Chairman of Cognitive Impairment and Dementia Committee of Chinese Medical Doctor Association, Chairman of China Cognition Disorders Society, President of China Dementia Society, Chairman of the Neurologist Society of Chinese Medical Doctor Association (2003-2013), President of Neurology committee of Chinese Medical Association (2009-2013). Professor Jia research interest includes Alzheimer's disease and its genetic pathogenesis; Clinical trial for cognitive disorders; Multi-center or national epidemiological survey of cognitive disease. Professor Jia is an experienced neurologist, also keen on the education of the medical student. He is the editor in chief of a series of neurology text book including Neurology(6th edition and 7th edition) and resident Neurology in China. He totally published 45 medical books, in which the editor in chief for 25 books.

)

Beijing Capital Medical University
45 Changchun Street, Beijing
PR China

Jeff Kuret (Biography
Jeff Kuret

Dr. Kuret is a Professor of Biological Chemistry and Pharmacology at The Ohio State University. He completed his undergraduate degree in Biochemistry at the University of California, Los Angeles and his Ph.D. degree in Pharmacology at Stanford University. Dr. Kuret’s laboratory focuses primarily on tau aggregation and neurofibrillary lesion formation in Alzheimer’s disease.

)

The Ohio State University
Columbus, OH
USA

Cynthia A. Lemere
Center for Neurologic Diseases, Harvard New Research Building
Boston, MA
USA

Davide V. Moretti
IRCCS S. Giovanni di Dio Fatebenefratelli
Brescia
Italy

Yasumasa Ohyagi (Biography
Yasumasa Ohyagi

Dr. Ohyagi graduated Kyushu University School of Medicine (Japan) in 1985. He is a clinical neurologist as well as neuroscientist in neurobiology and neurochemistry of Alzheimer’s disease. He worked at Case Western Reserve University and Mayo Clinic Florida (USA) from 1994 to 1997. After the professor of Neurological Therapeutics in Kyushu University, he became the professor and chairman of Department of Neurology and Geriatric Medicine in Ehime University (Japan) from 2015.

)

Kyushu University
Fukuoka
Japan

William Rebeck (Biography
William Rebeck

Bill Rebeck studies genetic risk factors for Alzheimer’s disease using cell culture and animal models. He received his AB in Chemistry from Cornell University (1982) and his PhD in Toxicology from Harvard University (1990). He studied Alzheimer’s Disease on a Fulbright Fellowship at the University of Heidelberg (1991) and APOE and Alzheimer’s Disease at Massachusetts General Hospital (1992-2002). In 2003, he joined the faculty of Georgetown University. In 2013-14, he was Interim Dean of the Graduate School of Arts and Sciences. He is a Professor in the Department of Neuroscience and Director of the Interdisciplinary PhD Program in Neuroscience.

)

Georgetown University Medical Center
Washington, DC
USA

Ahmad Salehi (Biography
Ahmad Salehi

Dr. Salehi (M.D., Ph.D.) is a Clinical Professor of Psychiatry and Behavioral Sciences at Stanford Medical School and the Director of the WRIISC Translational Laboratory at the VA Palo Alto Health Care System in California, USA. He studies how optimization of the noradrenergic system can be used to mitigate cognitive deficits associated with Down syndrome and Alzheimer’s disease. Salehi was recognized as the best junior scientist in the Netherlands in the field of Alzheimer’s disease and has received World Technology Award in the field of Biotechnology. Dr. Salehi is the Clinical Editor of Basic & Clinical Neuroscience and among his numerous articles, 7 have been featured on the cover of high impact factor international journals.

)

Stanford Medical School
Palo Alto, CA
USA

Dale Schenk
Elan Pharmaceuticals
San Francisco, CA
USA

Warren Strittmatter
Duke University Medical Center
Durham, NC
USA

Gopal Thinakaran
The University of Chicago
Chicago, IL
USA

Annalena Venneri
University of Sheffield
Sheffield, S10 2RX
UK

Shirley S. Yan
University of Kansas
Lawrence, KS
USA

Claudio Babiloni
University of Rome Sapienza
Rome
Italy

Ashley I. Bush
University of Melbourne
Parkville, VIC
Australia

Shengdi Chen (Biography
Shengdi Chen

Dr. Shengdi Chen obtained M.D. and Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine. Dr. Chen is currently a Professor and Chairman, Department of Neurology and Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China. His main interests are the studies of Parkinson’s disease, Alzheimer’s disease and related disorders. He has published more than 600 scientific publications papers and received 29 awards in the Parkinson’s disease and Alzheimer’s disease studies as well as 43 grant supports. Dr. Chen was the founding Editor (2012) and is currently the Editor-in-Chief of Translational Neurodegeneration journal, published by BioMed Central.

)

Shanghai Jiaotong University, School of Medicine
Shanghai
China

Scott E. Counts
Michigan State University
Grand Rapids, MI
USA

Abraham Fisher
Israel Institute for Biology Research
Ness-Ziona
Israel

Ezio Giacobini (Biography
Ezio Giacobini

Ezio Giacobini is since July 1995 a professor associated with the Dept. of Internal Medicine, Rehabilitation and Geriatrics, University of Geneva Medical School in Geneva, Switzerland and an Adjunct Professor of Pharmacology, Psychiatry and Neurology at the Southern Illinois School of Medicine, Springfield, IL, USA. He serves currently on the editorial board of seven international scientific journals and is the co-editor of a further four (Int. Journal of Developmental Neuroscience, Japanese Journal of Pharmacology, Int. Journal of Geriatric Psychopharmacology and the Journal of Neurotransmission). He was the vice-president of the European Soc. of Clinical Neuropharmacology (2000 – 2006). He received the LIFE TIME ACHIEVEMENT AWARD IN ALZHEIMER’S DESEASE RESEARCH from the Alzheimer Association (USA) at the 8th Int. Conference on Alzheimer’s Disease in Stockholm, July 2002.

)

University of Geneva Hospitals
Geneva
Switzerland

Christian Humpel
Medical University of Innsbruck
Innsbruck
Austria

Hong Jiang
Department of Physiology
Qingdao
P.R. China

Frank M. LaFerla
University of California
Irvine, CA
USA

Daniel Michaelson (Biography
Daniel Michaelson

Daniel M. Michaelson is Professor of Neurobiology at Tel Aviv University. He graduated from the Hebrew university in Jerusalem with a BSc in Physics and mathematics in 1968 and obtained in PhD in Biophysics from UC Berekely in 1973 . His post doctoral training was in neurochemistry at the labortatory of Professor M.A. Raftery at CalTech where he studied the nictonic acetylcholine and it's functional reconstitution He joined the faculty of life science at el Aviv university in 1974 where his research first focused on neurotransmitter release. His current research focuses on AD and the mechanisms underlying the effects of APOE4 the most prevalent genetic risk factor of AD. He is the incumbent of the Lebach chair in molecular Neurodegenration.

)

Tel Aviv University
Tel Aviv
Israel

Elliott Mufson
Barrow Neurological Institute
Phoenix, AZ
USA

Giulio Maria Pasinetti
Icahn School of Medicine at Mount Sinai
New York, NY
USA

P.Hemachandra Reddy
Garrison Institute on Aging, Texas Tech University Health Science Center
Lubbock, TX
USA

Kumar Sambamurti
Medical University of South Carolina
Charleston, SC
USA

Hermona Soreq (Biography
Hermona Soreq

Hermona Soreq has a PhD in Biochemistry from the Weizmann Institute of Science and is a founding member of the Edmond and Lily Safra Centre of Brain Science at The Hebrew University of Jerusalem, Israel, where she holds a Slesinger Chair of Molecular Neuroscience. Her major research interests are focused on the cholinergic signalling system and its molecular brain and body regulators, in particular microRNAs.

)

The Hebrew University of Jerusalem’s Science Faculty
Jerusalem
Israel

Manuel Górriz Sáez
University of Granada
Granada
Spain

Frederick W. Unverzagt (Biography
Frederick W. Unverzagt

Dr. Unverzagt is Professor of Psychiatry at Indiana University School of Medicine where he is Training Director for the Clinical Neuropsychology Residency. He serves on the editorial board of Neuropsychology, Journal of the International Neuropsychological Society, and Current Alzheimer Research. He served as President of the Indiana Psychological Association, Treasurer for the American Board of Clinical Neuropsychology, and board member for the Association of Post-doctoral Programs in Clinical Neuropsychology. He is a fellow of the American Psychological Association (Division 40) and the National Academy of Neuropsychology and recipient of the Indiana University Trustee Teaching Award, the Gordon A. Barrows Award for Distinguished Contributions to Psychology in Indiana (Indiana Psychological Association), Janet E. Rafferty Scientist-Practitioner Award (Southern Illinois University at Carbondale), and Distinguished Alumni Award for Career Achievement (Southern Illinois University at Carbondale).

)

Indiana University, School of Medicine
Indianapolis, IN
USA

Douglas Walker
Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University
Tempe, AZ
USA

Nasser H. Zawia
University of Rhodes Island
Kingston, RI
USA

Steven W. Barger (Biography
Steven W. Barger

Dr. Barger received a B.A. and the Spessard Award for Biology from Hendrix College and then obtained a Ph.D. in Cell Biology at Vanderbilt University. After a postdoctoral fellowship at the University of Kentucky, he became the first recipient of the Inglewood Fellowship for Alzheimer's research at the University of Arkansas for Medical Sciences, where is currently Professor in three departments: Geriatrics, Neurobiology & Developmental Sciences, and Internal Medicine. Since 1996, he has been jointly appointed at the Department of Veterans Affairs. Dr. Barger has published extensively in the field of neuroscience and neurological disease and has been funded nearly continuously by one or more grants from the National Institutes of Health since 1994. He is active on the editorial boards of five scientific journals. He is also an instructor and a research advisor for graduate students, including serving as course director for “The Basic Biology of Aging.

)

University of Arkansas for Medical Sciences
Little Rock, AR
USA

Giuseppina Cantarella (Biography
Giuseppina Cantarella

Dr. Cantarella obtained her MD degree from the University of Catania Medical School, and her Doctorate (Ph.D.) in Immunopharmacology from the University of Palermo, Italy. She held positions as Visiting Fellow and Visiting Scientist at The Weizmann Institute of Science, Rehovot, Israel, working with Professor Wallach on the discovery of novel proteins of TNF signaling pathway. Dr. Cantarella was thereafter appointed as an Assistant Professor of Pharmacology at the University of Catania Medical School and rapidly rose through the Academic ranks until appointed as Associate Professor of Pharmacology. Her research focuses on the role of neuroinflammation in neurodegenerative disorders.

)

DBCM, Sezione di Farmacologia
Catania
Italy

Jurgen A.H.R. Claassen (Biography
Jurgen A.H.R. Claassen

Dr. Claassen obtained his MD and PhD in Medicine from Radboud University, the Netherlands. He is a board certified geriatrician, and associate professor at the Radboud University Medical Center. He is also appointed as Principal Investigator at the Donders Institute. His research interests are cerebral hemodynamic regulation in aging and Alzheimer’s disease, hypertension, and syncope. Dr .Claassen has published over 100 scientific publications.

)

Radboud University Medical Center
Nijmegen
The Netherlands

A. Claudio Cuello
McGill University
Montreal, Quebec
Canada

Robert Friedland (Biography
Robert Friedland

Dr. Friedland (MD, Mount Sinai School of Medicine, New York, 1973) completed a fellowship in brain aging and dementia at the Albert Einstein College of Medicine in New York and worked as Chief Neurologist at the Donner Laboratory, University of California Berkeley. His work has focused on multidisciplinary approaches to neurodegenerative diseases. Dr. Friedland sees patients with a focus on cognitive/behavioral/geriatric neurology. He is interested in preventive medicine and has been involve in research studies in the Middle East, Africa and Japan. He has authored or coauthored over 200 scientific publications in refereed journals and his work has been cited over 10,000 times. His current approach to the mechanisms of initiation of neurodegeneration developed from a longstanding interest in the biology of brain aging.

)

University of Louisville, School of Medicine
Louisville, KY
USA

Yian Gu (Biography
Yian Gu

Dr. Yian Gu obtained a doctorate (Ph.D.) in Epidemiology from New York University, New York. During her postdoctoral training at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, she applied nutritional epidemiology to understand the role of dietary factor in Alzheimer’s disease, cognitive decline in the elderly, as well as many other neurodegenerative diseases. Currently Dr. Gu is an Assistant Professor in the Department of Neurology, Columbia University, New York. She has published more than 50 scientific peer-reviewed articles and book chapters.

)

Taub Institute for Research in Alzheimer’s Disease and the Aging Brain
New York, NY 10032
USA

Nibaldo C. Inestrosa
Catholic University of Chile
Santiago
Chile

Rajesh Kalaria
Newcastle University
Newcastle upon Tyne
UK

Hyoung-gon Lee
Case Western Reserve
Cleveland, OH
USA

Paula I. Moreira
University of Coimbra
Coimbra
Portugal

Agneta Nordberg
Karolinska Institute
Huddinge
Sweden

Huntington Potter (Biography
Huntington Potter

Dr. Huntington Potter is Professor of Neurology, a member of the Linda Crnic Institute for Down Syndrome and Director of the University of Colorado Alzheimer’s Disease Research Center. He studied, researched and taught for 30 years at Harvard University, and then designed and directed the Florida-wide Byrd Alzheimer’s Center & Research Institute. He is author of over 100 scientific articles, books and patents, is a Fellow of the AAAS and the National Academy of Inventors. His electron micrographs of DNA are on permanent exhibit in the Smithsonian Institute.

)

Linda Crnic Institute for Down Syndrome
Aurora, CO
USA

Jack T. Rogers
Harvard Medical School, MGH
Charleston, MA 02129
USA

Andrew J. Saykin
Indiana University School of Medicine
Indianapolis, IN
USA

Rosanna Squitti (Biography
Rosanna Squitti

Dr. Squitti, PhD, is the Head of the Laboratory of Biology, at the Fatebenefratelli Foundation – AFaR Division -, of the St John Calibita at Fatebenefratelli Hospital in Rome, Isola Tiberina, Italy. Dr. Squitti was born in Rome, Italy. She received her Master Degree (‘Laurea’) in Biology (25 May 1993) from the University of Rome ‘La Sapienza’. In 2015 she became Research Director of IGEA Research Corporation, Miami, US. In 2016 she started collaborating with University of Miami, Florida, US as Voluntary Faculty Research Professor. In 2016 she was hired as senior researcher in Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio- Fatebenefratelli, Brescia, Italy. She has published more than 100 scientific publications and is a named inventor of 2 U.S patents.

)

Department of Neuroscience
Rome
Italy

Jordan Tang
Oklahoma Medical Research Foundation
Oklahoma City, OK
USA

Robert Vassar
NWU Medical Center
Chicago, IL
USA

Bengt Winblad (Biography
Bengt Winblad

Professor Bengt Winblad, MD, PhD has been involved in the field of dementia research for many years. Since 1987, he is working in Stockholm, Sweden as Professor of Geriatric Medicine at the Karolinska Institute and is co-heading the Clinical Trial Unit at the Karolinska University Hospital in Huddinge. Professor Winblad was the first Director of the Alzheimer Research Center at Karolinska Institute. He is the Director of the Swedish Brain Power research network. Bengt Winblad’s research interests are experimental and clinical Alzheimer research with a translational approach and focus on early diagnosis and treatment. He was in 2009 ranked the world’s most prolific researcher in the Alzheimer field (J Alzheimer’s Disease 2009).

)

Karolinska Institute
Stockholm
Sweden


Special Staff Member:

Wang Wei
School of Pharmacy,Hunan University of Chinese Medicine, Hanpu Science & Technology Park
Changsha, Hunan
China 410208


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science